SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA conducts inspection at Marksans Pharma’s Goa facility

07 Mar 2019 Evaluate

US Food and Drug Administration (USFDA) has concluded inspection of Marksans Pharma’s Goa facility. The inspection of the facility took place between February 25 to March 6, 2019, resulting in a Form 483 with eight observations. None of these observations are considered either critical or repetitive in nature.

The company is highly confident of closing these expeditiously and remains committed to global standards of quality & compliance. The site will continue to supply to the US markets all approved ANDA's. This inspection will help company to received pending ANDA's approval already filed by it.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.

Marksans Pharma Share Price

179.55 -0.95 (-0.53%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×